Squarex Pharmaceutical Corpの企業情報(従業員数・代表者名など)
企業情報
特色 | Squarex Pharmaceutical Corporation is a pharmaceutical company. The Company is engaged in developing a late-clinical-stage drug to improve immune function to reduce severity and incidence of infectious disease with an initial focus on oral herpes. The Company's drug SQX770 has completed a Phase I and a Phase II placebo-controlled clinical trial. SQX770 contains the active ingredient squaric acid dibutyl ester (SADBE). The SQX770 drug is topically applied on a patient's arm, not the face or lip or a lesion. |
---|---|
英文社名 | Squarex Pharmaceutical Corp |
本社所在地 | 1000 Westgate Dr, Suite 1010 SAINT PAUL, MN 55114 USA |
電話番号 | 651 207-8270 |
設立年月 | 2012年1月 |
代表者名 | Hugh Mctavish |
業種名 | 一般消費財(Consumer Products) |
市場名 | --- |
従業員数 | 2人 |
ウェブサイト | https://squarex-pharma.com/ |